@article{86a3d4f93093420e83fc68cbda5e45eb,
title = "Increased reporting of cerebrovascular accidents with use of risankizumab observed in the Food and Drug Administration Adverse Events Reporting System (FAERS)",
keywords = "United States, Humans, United States Food and Drug Administration, Adverse Drug Reaction Reporting Systems, Product Surveillance, Postmarketing, Stroke/chemically induced, Drug-Related Side Effects and Adverse Reactions",
author = "Alexander Egeberg and Thyssen, {Jacob P}",
year = "2023",
month = may,
day = "24",
doi = "10.1093/bjd/ljad039",
language = "English",
volume = "188",
pages = "793--794",
journal = "British Journal of Dermatology",
issn = "0007-0963",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "6",
}